RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
Sara Egea‐Rodriguez(West German Heart and Vascular Center Essen), Iris Helfrich(German Cancer Research Center)
Cited by 2
Related Papers
The burden of constipation on quality of life: results of a multinational survey
|Alimentary Pharmacology & Therapeutics|2007|369
A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation
|Alimentary Pharmacology & Therapeutics|2008|272
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
|Frontiers in Immunology|2020|38
Persister state-directed transitioning and vulnerability in melanoma
|Nature Communications|2022|35
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
|Journal for ImmunoTherapy of Cancer|2023|31